Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Operating Expenses (2018 - 2025)

AVITA Medical's Operating Expenses history spans 8 years, with the latest figure at $24.7 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 5.23% year-over-year to $24.7 million; the TTM value through Dec 2025 reached $101.4 million, down 9.3%, while the annual FY2025 figure was $101.4 million, 9.31% down from the prior year.
  • Operating Expenses reached $24.7 million in Q4 2025 per RCEL's latest filing, up from $23.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $30.2 million in Q3 2024 to a low of $12.3 million in Q3 2021.
  • Average Operating Expenses over 5 years is $20.9 million, with a median of $21.2 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: crashed 32.95% in 2021, then soared 64.41% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $12.3 million in 2021, then grew by 22.74% to $15.0 million in 2022, then skyrocketed by 64.41% to $24.7 million in 2023, then grew by 5.47% to $26.1 million in 2024, then fell by 5.23% to $24.7 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Operating Expenses are $24.7 million (Q4 2025), $23.0 million (Q3 2025), and $26.1 million (Q2 2025).